nitrendipine has been researched along with Respiratory Distress Syndrome in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, C | 1 |
Xu, DZ | 1 |
Feketeova, E | 1 |
Kannan, KB | 1 |
Fekete, Z | 1 |
Deitch, EA | 1 |
Livingston, DH | 1 |
Hauser, CJ | 1 |
1 other study available for nitrendipine and Respiratory Distress Syndrome
Article | Year |
---|---|
Store-operated calcium channel inhibition attenuates neutrophil function and postshock acute lung injury.
Topics: Animals; Calcium; Calcium Channel Blockers; CD11b Antigen; Chemotaxis, Leukocyte; Disease Models, An | 2005 |